521 related articles for article (PubMed ID: 30501950)
21. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
[TBL] [Abstract][Full Text] [Related]
22. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor.
Verdoia M; Nardin M; Gioscia R; Negro F; Marcolongo M; Suryapranata H; Kedhi E; De Luca G;
Vascul Pharmacol; 2020 Sep; 132():106765. PubMed ID: 32681888
[TBL] [Abstract][Full Text] [Related]
23. Comparison of major bleeding in patients with acute coronary syndrome that underwent coronary artery bypass grafting treated with clopidogrel or ticagrelor: a systematic review and meta-analysis.
Rohman MS; Purnamasari Y; Ilmawan M; Mahdi BA; Tamara F; Mahendra AI; Mazen M; Heriansyah T; Yamin M; Pikir BS; Fajar JK
F1000Res; 2020; 9():99. PubMed ID: 33732438
[No Abstract] [Full Text] [Related]
24. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
[TBL] [Abstract][Full Text] [Related]
25. Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study.
Yao Y; Wang P; Wang XZ; Zhao X; Zhao W; Zhou TN; Zhang L
Chin Med J (Engl); 2019 Oct; 132(19):2292-2299. PubMed ID: 31567375
[TBL] [Abstract][Full Text] [Related]
26. Ticagrelor-based antiplatelet regimens in patients treated with coronary artery bypass grafting: a meta-analysis of randomized controlled trials.
von Scheidt M; Bongiovanni D; Tebbe U; Nowak B; Stritzke J; Zhao Q; Zhu Y; Kastrati A; Cassese S; Schunkert H
Eur J Cardiothorac Surg; 2020 Mar; 57(3):520-528. PubMed ID: 31566205
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.
Hansson EC; Jidéus L; Åberg B; Bjursten H; Dreifaldt M; Holmgren A; Ivert T; Nozohoor S; Barbu M; Svedjeholm R; Jeppsson A
Eur Heart J; 2016 Jan; 37(2):189-97. PubMed ID: 26330426
[TBL] [Abstract][Full Text] [Related]
29. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA.
Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
Aging (Albany NY); 2020 Oct; 12(20):20085-20094. PubMed ID: 33065552
[TBL] [Abstract][Full Text] [Related]
30. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
[TBL] [Abstract][Full Text] [Related]
31. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation.
Trejo-Velasco B; Tello-Montoliu A; Cruz-González I; Moreno R; Baz-Alonso JA; Salvadores PJ; Romaguera R; Molina-Navarro E; Paredes-Galán E; Fernández-Barbeira S; Ortiz-Saez A; Bastos-Fernandez G; De Miguel-Castro A; Figueiras-Guzman A; Iñiguez-Romo A; Jimenez-Diaz VA
J Cardiovasc Pharmacol; 2021 Sep; 78(3):463-473. PubMed ID: 34117181
[TBL] [Abstract][Full Text] [Related]
32. Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome.
Caiazzo G; De Rosa S; Torella D; Spaccarotella C; Mongiardo A; Giampà S; Micieli M; Palella E; Gulletta E; Indolfi C
Circ Cardiovasc Interv; 2014 Feb; 7(1):104-12. PubMed ID: 24449597
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Antiplatelet Effects of Once and Twice Daily Low-Dose Ticagrelor and Clopidogrel After Percutaneous Coronary Intervention.
Choi KN; Jin HY; Shin HC; Park YA; Seo JS; Jang JS; Yang TH; Kim DK; Kim DS
Am J Cardiol; 2017 Jul; 120(2):201-206. PubMed ID: 28554486
[TBL] [Abstract][Full Text] [Related]
34. Effect of ticagrelor and clopidogrel dual antiplatelet therapy on MPVLR, MAADP, and AA inhibition rate in acute coronary syndrome patients after percutaneous coronary intervention.
Gao ST; Wang Y; Ma L
Medicine (Baltimore); 2023 Sep; 102(37):e34974. PubMed ID: 37713840
[TBL] [Abstract][Full Text] [Related]
35. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.
Hage A; Voisine P; Erthal F; Larose É; Glineur D; Chow B; Tremblay H; Fortier J; Ko G; Une D; Farkouh M; Mesana TG; LeMay M; Kulik A; Ruel M
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):212-222.e2. PubMed ID: 28734623
[TBL] [Abstract][Full Text] [Related]
36. Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639].
Gasparovic H; Petricevic M; Kopjar T; Djuric Z; Svetina L; Biocina B
Trials; 2012 Aug; 13():148. PubMed ID: 22920307
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
[TBL] [Abstract][Full Text] [Related]
38. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
[TBL] [Abstract][Full Text] [Related]
39. A Randomized Trial of Clopidogrel vs Ticagrelor After Off-Pump Coronary Bypass.
Kim HH; Yoo KJ; Youn YN
Ann Thorac Surg; 2023 May; 115(5):1127-1134. PubMed ID: 36395875
[TBL] [Abstract][Full Text] [Related]
40. Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis.
Vuilliomenet T; Gebhard C; Bizzozero C; Glauser S; Blum S; Buser A; Bolliger D; Grapow MTR; Siegemund M
Interact Cardiovasc Thorac Surg; 2019 May; 28(5):665-673. PubMed ID: 30535154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
